Aquilo Capital, L.P., 10% Owner at Spero Therapeutics, Inc. (SPRO), bought 79,454 shares at $5.24 ($416K) on 2022-04-26, disclosed to the SEC on 2022-04-28.
Open-market purchase of $416k SPRO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.24 | 39,727 | $208K | 50.0% |
| 2 | $5.24 | 39,727 | $208K | 50.0% |
| Total | $5.24 avg | 79,454 | $416K | 100% |
| Filing → |
| SPRO | BUY | 2022-01-26 | $17K | — | Filing → |
| SPRO | BUY | 2021-11-02 | $2.6M | — | Filing → |
| SPRO | BUY | 2021-10-04 | $5.0M | — | Filing → |